High-dose bendamustine plus brentuximab combination is effective and has a favourable toxicity profile in the treatment of refractory and relapsed Hodgkin lymphoma
Cerchione, C., Di Perna, M., Della Pepa, R., Pugliese, N., Pane, F., Picardi, M.Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2439_58
Date:
June, 2017
File:
PDF, 99 KB
english, 2017